The Impact of Federal Funding Cuts on Patients, Providers, and the Field of Reproductive Medicine.
The use of hormonal contraception can be considered to aid in the timing of assisted reproductive technology cycles, reduce the risk of ovarian cysts at in vitro fertilization cycle initiation,
Clinical trials testing infertility treatments often do not report on the major outcomes of interest to patients and clinicians and the public (such as live birth) nor on the harms, including
The use of preimplantation genetic testing for aneuploidy (PGT-A) in the United States has been increasing steadily.
Methodological limitations in studying the association between the use of fertility drugs and cancer include the inherent increased risk of cancer in women who never conceive, the increased risk
ASRM’s scorecard guides voters on IVF and reproductive health positions of federal officials, with color indicators showing support or opposition to key bills
IVF is essential for many families. Restorative Reproductive Medicine is no substitute, risking access to proven fertility care in the U.S.
ASRM's "Opposition Rebuttal" fact sheet counters common arguments against assisted reproductive technologies, offering evidence-based support for ART practices.
Displaying 121 to 130 of 1735 records
